|
Commitments and Contingencies - Additional Information (Detail) (USD $)
|
12 Months Ended | 0 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
Texas A and M University [Member]
Milestone
|
Dec. 31, 2012
Texas A and M University [Member]
|
Dec. 31, 2013
Texas A and M University [Member]
Phase I Clinical Trial [Member]
|
Dec. 31, 2013
Texas A and M University [Member]
Phase II Clinical Trial [Member]
|
Dec. 31, 2013
Texas A and M University [Member]
Phase III Clinical Trial [Member]
|
Dec. 31, 2013
Office Space Lease Alachua [Member]
|
Dec. 31, 2011
Office Space Lease Alachua [Member]
|
Oct. 02, 2009
Office Space [Member]
sqft
|
Dec. 31, 2012
Office Space [Member]
|
Oct. 31, 2013
Office Space Lease Two [Member]
sqft
|
Dec. 31, 2013
Office Space Lease Two [Member]
|
Oct. 31, 2013
Office Space Lease Two [Member]
Minimum [Member]
|
Oct. 31, 2013
Office Space Lease Two [Member]
Maximum [Member]
|
Dec. 31, 2013
UFRF License Agreements [Member]
|
Dec. 31, 2013
Lantibiotic ECC [Member]
Milestone
|
Dec. 31, 2013
Lantibiotic ECC [Member]
Investigational New Drug Application [Member]
|
Dec. 31, 2013
Lantibiotic ECC [Member]
Clinical Study Phase 2 [Member]
|
Dec. 31, 2013
Lantibiotic ECC [Member]
Clinical Study Phase 3 [Member]
|
Dec. 31, 2013
Lantibiotic ECC [Member]
Filing of First Investigational New Drug Application [Member]
|
Dec. 31, 2013
Lantibiotic ECC [Member]
First Regulatory Approval of Oragenics Product [Member]
|
Dec. 31, 2013
Probiotics ECC [Member]
Milestone
|
|
| Commitment And Contingencies [Line Items] | |||||||||||||||||||||
| Period of lease | 3 years | 40 months | 39 months | ||||||||||||||||||
| Percentage of insurance exceed | 3.00% | ||||||||||||||||||||
| Deposit made | $ 9,360 | ||||||||||||||||||||
| Monthly lease payments | 9,922 | 5,276 | 6,426 | 6,818 | |||||||||||||||||
| Rent expense | 119,064 | 58,036 | 59,492 | ||||||||||||||||||
| Area of lease | 3,150 | 4,168 | |||||||||||||||||||
| Lease expiration date | Nov. 30, 2012 | Feb. 28, 2017 | |||||||||||||||||||
| Company's obligation to pay from percentage of selling price of product | 5.00% | ||||||||||||||||||||
| Company's obligation to pay from all revenue received from sublicenses | 22.00% | ||||||||||||||||||||
| One-time commercialization fee would be due on the first anniversary of first commercial sale | 5,000 | ||||||||||||||||||||
| Post-commercialization minimum royalty payments | 50,000 | ||||||||||||||||||||
| One-time additional royalty payment would be due when total cumulative royalties | 2,000,000 | ||||||||||||||||||||
| Total royalties due to UFRF | 10.00% | ||||||||||||||||||||
| Minimum annual maintenance payment per license agreement | 10,000 | ||||||||||||||||||||
| Aggregate minimum annual maintenance payment | 20,000 | ||||||||||||||||||||
| Quarterly maintenance payment to UFRF under installment plan | 5,000 | ||||||||||||||||||||
| Initial payment to Texas A&M | 5,000 | ||||||||||||||||||||
| Minimum royalty to Texas A&M | 5.00% | ||||||||||||||||||||
| Minimum royalty for stacking | 2.00% | ||||||||||||||||||||
| Minimum consideration for the continuation of the license agreement | 15,000 | ||||||||||||||||||||
| Minimum annual amount to Texas A&M | 100,000 | 0 | |||||||||||||||||||
| Annual maintenance payment under licensing agreement with Texas A&M | 100,000 | ||||||||||||||||||||
| Date of milestone achievement under licensing agreement with Texas A&M | Jun. 01, 2025 | Jun. 01, 2015 | Jun. 01, 2019 | Jun. 01, 2022 | |||||||||||||||||
| Maintenance payment under licensing agreement with Texas A&M | 400,000 | 50,000 | 100,000 | 150,000 | |||||||||||||||||
| Maximum period to cure the breach | 60 days | 60 days | |||||||||||||||||||
| Percentage company pay on quarterly basis out of gross profit | 25.00% | ||||||||||||||||||||
| Company's obligation to make payment from all revenue received from sublicensing | 50.00% | ||||||||||||||||||||
| Number of shares issued | 4,392,425 | ||||||||||||||||||||
| Percentage of number of shares of common stock equal to Base Shares | 1.00% | 1.50% | 2.00% | 2.50% | 3.00% | ||||||||||||||||
| Maximum percentage of primary investment securities to investment of shares issued | 10.00% | ||||||||||||||||||||
| Number of milestones achieved | 0 | 0 | 0 | ||||||||||||||||||
| Termination notice period | 90 days | 90 days | 90 days | 90 days | |||||||||||||||||
| Obligation to pay as percentage of Gross Profit | 25.00% | ||||||||||||||||||||
| Obligation to pay as percentage of Revenue | 10.00% | ||||||||||||||||||||
| Milestone amount payable one | 2,000,000 | ||||||||||||||||||||
| Milestone measurement period | 30 days | ||||||||||||||||||||
| Milestone amount payable two | 5,000,000 | ||||||||||||||||||||
| Milestone amount payable three | $ 10,000,000 | ||||||||||||||||||||